IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

Size: px
Start display at page:

Download "IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)"

Transcription

1 IF YOU ARE RECEIVING (NATALIZUMAB) TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS Read the patient information leaflet that accompanies the medicine carefully. 1

2 This brochure is a supplement to the healthcare provider s patient information on TYSABRI. IF YOU ARE RECEIVING TYSABRI This brochure is for people who have MS and whose doctor has prescribed the drug TYSABRI (natalizumab). You will find more information about TYSABRI, how the drug works, what effects you can expect, and any side effects. It also contains a brief background about the disease, what happens in your body and how it can affect you. Do not hesitate to contact your doctor or MS nurse if there is anything you wonder about, or need an answer to. Please read the package leaflet that is enclosed with TYSABRI before you start your treatment. This medicinal product is subject to additional monitoring. The black triangle is intended to be used in all EU member states to identify those medicines that are under additional monitoring, which means that the medicine is monitored more closely than other medicines. The black triangle makes it possible to quickly identify which medicines are under additional monitoring. Patients and healthcare personnel in particular are encouraged to report all suspected side effects of a medicine that is marked with the black triangle so that new information can be quickly evaluated. More information is available on 2

3 CONTENTS Facts about MS... 4 How TYSABRI acts... 7 Facts about the treatment... 9 Questions and answers Other information Terminology

4 FACTS ABOUT MS In Sweden about 18,000 people have multiple sclerosis, MS, and about 1,000 people become ill every year. MS is a neurological disease that affects the central nervous system (brain and spinal cord). The central nervous system can be described as the body's "computer". Nerve cells in the central nervous system receive and send out large amounts of information through the nerve fibres or "axons". The nerve fibres join the nerve cells together in an enormous network. The information is passed between the nerve cells as weak electrical impulses along the nerve fibres. The nerve fibres are surrounded by a fatty layer called myelin. This has an insulating effect so that the electrical signals travel quickly and efficiently. Healthy nerve fibre: Nerve cells send information through nerve fibres as electrical signals to other cells. The nerve fibres are surrounded by myelin, a fatty layer that acts as insulation and makes it easier for the electrical signals to travel. Damaged nerve fibre: The myelin has broken down making it difficult for the signals to travel between the nerve cells. 4

5 In MS, small inflammations occur in the brain or spinal cord. These damage the myelin causing it to break down. This makes it more difficult for the electrical signals to move through the affected area. The brain's ability to communicate effectively with the various parts of the body is affected. This makes it more difficult for the brain to control the nerves for motor function (movement) or to process sensory input. Most people with MS have relapses. This means that they have periods with symptoms due to new damage followed by better periods with weaker or no symptoms at all. The inflammation in MS can occur in different parts of the central nervous system. This means many bodily functions can be affected and the symptoms can vary from relapse to relapse and from person to person. Cerebrum Cerebellum Brain stem Spinal cord When the inflammation in the central nervous system has subsided, the nervous system can repair itself and rebuild the myelin around the nerve fibres. Occasionally the damage persists. In the long term, this persistent damage in the central nervous system increases and can cause increasing impairment of function. It is therefore important when choosing the treatment for MS to weigh up the advantages and risks of the treatment against the risks associated with the disease itself. 5

6 In time treatment At the beginning in relapsing-remitting MS there is often complete recovery after a relapse. The brain's repair cells build up new myelin around the nerve fibres. But new inflammations can lower the possibility for recovery. Once the myelin has broken down, the nerve fibre itself can be attacked and destroyed. Damage that occurs as a result of broken down nerve fibres or dead nerve cells can become permanent. This is why it is important to check as early as possible how active your disease is before damage occurs that the body cannot repair. If you are an adult with highly active relapsing-remitting MS you can be treated with TYSABRI. This means: Continued disease activity in spite of treatment with other disease-modifying drugs or High disease activity when the disease first appeared. 6

7 FACTS ABOUT TYSABRI How TYSABRI acts In MS, immune cells pass from the blood stream into the central nervous system. For some unknown reason, the immune cells have become programmed to attack the myelin, the insulating layer around the nerve fibres. TYSABRI is an antibody that affects the immune system and thus MS. TYSABRI prevents the cells that cause the inflammation in MS from entering the central nervous system by attaching to the immune cells' "keys". This means that the "keys" do not fit the "keyhole" in the central nervous system. This reduces the risk of new nerve damage. Nerve fibre with myelin Blood stream The immune cells 7

8 WHAT YOU CAN EXPECT FROM THE TREATMENT The best way to study and demonstrate the effects of a drug is to conduct so-called clinical studies. Researchers study how the disease develops in patients who receive the drug compared with a control group who receive a placebo (a drug with no effect). In clinical studies, TYSABRI almost halved the rate at which function impairment developed in MS, and it also reduced the number of MS relapses by about two-thirds. How will I know whether TYSABRI has an effect? When you are treated with TYSABRI you are regularly monitored for any effect. All relapses are noted, and any changes in physical and cognitive functions (capacity to move and think) are monitored. If you experience that your disease does not stabilise when treated with TYSABRI, you should discuss with your doctor whether this is the right treatment for you. If you are treated with TYSABRI you are followed up regularly for treatment effects 8

9 FACTS ABOUT THE TREATMENT One infusion every four weeks TYSABRI is administered as an intravenous infusion, this is a drip into a blood vessel in the arm. The drip is administered in the hospital Reception or on a Day Ward every fourth week by healthcare personnel and takes about an hour. In connection with the infusion you are checked for any allergic reactions; but these are uncommon. Attending the hospital every four weeks can offer additional security. These regular visits mean it will also be easy for healthcare personnel and your doctor to monitor the effects of your treatment. Patient information card You will be given a patient card which contains important information on TYSABRI. Show the card to all doctors and other healthcare personnel involved in your treatment. Show the patient card to your partner and family too, so that they are familiar with the treatment with TYSABRI and what they should be aware of. PATI INFOENT RMA TION CARD FOURTH EVERY WEEK 9

10 Side effects Most medicines give some side effects and that applies to TYSABRI as well. Most of the side effects with TYSABRI are mild and soon disappear. A small number of patients react with hypersensitivity associated with the infusion. The reaction normally occurs within a few hours and may mean that you need to stay behind for observation after the infusion. Other common side effects include urinary tract infections, sore throats and runny or blocked nose, shaking, itchy rashes (urticaria), headache, dizziness, nausea, vomiting, joint pain, fever and tiredness. Talk to your doctor if you experience any side effects. The patient information leaflet enclosed with TYSABRI contains more information on the side effects. PML an uncommon but serious infection In rare cases, treatment with TYSABRI has resulted in PML, progressive multifocal leukoencephalopathy. PML is an infection in the brain that can give serious consequences, including damage to the central nervous system in people who are affected. The infection is caused by a virus called the JC virus. About half the population carry this virus without it causing them any problems or disease. If you are treated with TYSABRI and carry the JC virus, there is a certain risk that you could develop PML. Carrying the virus does not mean that you will get PML; this is just one of three known risk factors The known risk factors are: Being a carrier of the JC virus, which is necessary for development of PML. If you are a carrier of the JC virus your risk is also affected by: How long the treatment is continued. Previous treatment with an immunosuppressive drug, which means a drug that inhibits the body s defence systems. 10

11 TYSABRI was approved in In June 2015 about 142,000 MS patients around the world had been treated with TYSABRI. Individual assessment of the treatment and follow-up A simple blood test is used to determine whether there are antibodies to the JC virus in the blood. If antibodies are present, the test result will be positive ; this means the virus is present in the body. If you do not have antibodies to the JC virus the test result is negative. This test helps you and your doctor assess the risk of PML and helps to ensure that you get the best treatment and follow-up. Important to be alert The symptoms with PML are similar to the symptoms with MS. It is therefore important that if you are receiving TYSABRI you are alert, and immediately contact your doctor if you feel your MS is getting worse or if you experience new symptoms. This will enable us to exclude early that it is PML. Tell your close family about the treatment so that they can help you notice any changes or worsening of your condition. 11

12 QUESTIONS AND ANSWERS What happens if I am hypersensitive to TYSABRI? If you are found to be hypersensitive to TYSABRI you will most probably not be allowed to continue the treatment with TYSABRI What happens if I become pregnant? Tell your doctor if you are pregnant, believe you are pregnant or are planning to become pregnant. You must not use TYSABRI if you are pregnant unless you have first discussed this with your doctor. Many people experience a significant improvement in their MS while they are pregnant. However, a few months after giving birth there is an increased risk of a relapse. Can I breastfeed? You must not breastfeed if you are being treated with TYSABRI. Discuss with your doctor when deciding whether to breastfeed or receive TYSABRI. Can I drive a car? TYSABRI is not expected to affect your ability to drive a car or use machinery. Talk to your doctor if you are uncertain. Can I take other medicines? Tell your doctor if you take or have recently taken other medicines. This also applies to herbal products and over-the-counter medicines. Can I stop my treatment temporarily? After each infusion TYSABRI disappears slowly from the body. TYSABRI is therefore given every fourth week to ensure that there is sufficient medicine in the blood. If the time between infusions is longer than four weeks, the effect of the treatment may be reduced and the activity of your MS could increase. Any temporary pause in your treatment, for example in connection with pregnancy, must be discussed with your doctor. 12

13 OTHER INFORMATION Talk to your doctor or nurse if you have any questions about your disease or treatment. They have the best overview of your treatment and situation. provides more information and reports on MS. More information on TYSABRI: read the patient information leaflet on FASS.se. See also 13

14 QUESTIONS I MUST REMEMBER TO ASK THE DOCTOR 14

15 TERMINOLOGY Antibody Proteins that are used by the body s immune system to detect and identify foreign substances such as viruses or bacteria. If the body forms antibodies against a given substance this is a sign that the substance is present in the body. Autoimmune disease A disease in which the immune system attacks the body s own tissues. Examples include MS and rheumatoid arthritis. Axon Nerve fibre that links nerve cells together with other cells Central nervous system (CNS) Comprises the brain and spinal cord and acts as the body s control and communication centre. Cognition The capacity to think, plan and remember. Disease-modifying drug A medicine that slows the progression of a chronic disease. TYSABRI is an example of a disease-modifying drug. Function impairment Reduced ability to function physically or mentally. Immune system The collective name for the body s complex defence mechanisms against infections. Immunosuppressive drug Medicine that is used to inhibit and slow the body s immune system so that it does not reject foreign substances in the body, for example after a transplant. Inflammation Reaction to damage to a tissue. Infusion Supply of a medicine, for example through a drip into a blood vessel in the arm. JC virus, JCV A virus that is carried by about half the population without it causing disease. When treated with TYSABRI, the JC virus has been shown to give an increased risk of developing PML. Multiple sclerosis Means many scars, and denotes the scars in the nervous tissue after the inflammatory reaction has ceased. Myelin The fatty sheath that protects the nerve fibres and makes it possible for the electrical signals to travel through the nerve fibres. Damage to the myelin makes it difficult for the signals to travel through the fibres. Natalizumab The active substance in TYSABRI. Natalizumab is an antibody that is similar to the antibodies produced by the body. Nerve Expressed simply, it is a type of cell that sends signals from various parts of the body to the brain and from the brain out to the body. Nerve fibre Another name for an axon, a projection on a nerve cell through which signals are sent to other cells. Patient information leaflet The printed information that is enclosed with a medicine. This information is also available on FASS.se. Placebo A medicine that does not contain any active ingredients. Is used for comparison in medical trials when studying the effect of a given medicine. PML Progressive multifocal leukoencephalopathy is a rare and serious virus infection in the brain. Quality of life The term quality of life is used to measure the subjective feeling of having a good life. This can be studied over time using various methods. Relapse A disease episode with a period of worsening due to new damage to the myelin. Side effect An unexpected or unintended effect of a medicine. 15

16 The information in this brochure is intended to form part of the information on TYSABRI provided for the patient by the treating doctor. The text is based on the patient information leaflet and the Summary of Product Characteristics for TYSABRI. See also TY-SWE-0191 / November 2015 TYSABRI (natalizumab), 300 mg concentrate for solution for infusion. Read the patient information leaflet before you start treatment with TYSABRIL. This drug is under additional monitoring. t Indications: Tysabri is intended for patients with highly active relapsing-remitting multiple sclerosis in spite of treatment with beta-interferon or glatiramer acetate; or patients with rapidly developing severe relapsing-remitting multiple sclerosis. Posology and method of administration: Tysabri is administered as a 300 mg infusion every four weeks under monitoring by healthcare personnel. Special warnings and precautions for use: Treatment with TYSABRI has been associated with an increased risk for PML, progressive multifocal leukoencephalopathy. Before start of treatment with Tysabri results of magnetic resonance imaging (MRI) performed within the last three months must be available for reference. The patients must be regularly checked for new or worsened neurological symptoms or status findings that could indicate PML Contraindications: Hypersensitivity to natalizumab or any of the excipients listed in the contents. Progressive multifocal leukoencephalopathy (PML). Patients with an increased risk for opportunistic infections, including patients with a compromised immune system. Combination with beta-interferons or glatiramer acetate. Known active cancers with the exception of patients with dermal basal cell cancer. Children and adolescents less than 18 years of age. Based on the Summary of Product Characteristics: 09/ Biogen Sweden AB Kanalvägen 12, Floor 7, Upplands Väsby Tel Fax

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

Multiple sclerosis disease-modifying drugs second line treatments

Multiple sclerosis disease-modifying drugs second line treatments Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction

More information

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy (DMT) means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Understanding How Existing and Emerging MS Therapies Work

Understanding How Existing and Emerging MS Therapies Work Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of

More information

Teriflunomide (Aubagio) 14mg once daily tablet

Teriflunomide (Aubagio) 14mg once daily tablet Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision

More information

Natalizumab (Tysabri)

Natalizumab (Tysabri) Natalizumab (Tysabri) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 Natalizumab (Tysabri) Date of issue: July 2010 Review date: July 2011 Contents Section

More information

The MS Disease- Modifying Drugs. Gener al information

The MS Disease- Modifying Drugs. Gener al information The MS Disease- Modifying Drugs Gener al information Current as of October 30, 2009. This online version is updated as breaking news requires. If you have downloaded and printed a copy from the web, please

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION LEMTRADA (alemtuzumab) Concentrate for solution for intravenous infusion This leaflet is part III of a three-part "Product Monograph" published when LEMTRADA (alemtuzumab)

More information

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment.

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment. Drug information Rituximab Rituximab This leaflet provides information on rituximab and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets entirely

More information

MS Treatments Gilenya

MS Treatments Gilenya 1 MSology Essentials Series Gilenya (fingolimod) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Trudy Campbell Dalhousie MS Research Unit, Capital Health, Halifax,

More information

Infliximab is used to treat psoriasis, psoriatic arthritis, and several other inflammatory conditions, including other inflammatory skin diseases.

Infliximab is used to treat psoriasis, psoriatic arthritis, and several other inflammatory conditions, including other inflammatory skin diseases. INFLIXIMAB What are the aims of this leaflet? This leaflet has been written to help you understand more about the medication infliximab. It tells you what it is, how it works, how it is used to treat skin

More information

RITUXIMAB (Rituxan) Rituximab 2007 Page 1 of 5

RITUXIMAB (Rituxan) Rituximab 2007 Page 1 of 5 RITUXIMAB (Rituxan) Rituximab is FDA approved for the treatment of low-grade or follicular CD20-positive, B-cell non-hodgkin's lymphoma (NHL); treatment of diffuse large B-cell CD20-positive NHL; treatment

More information

An introduction to modern MS treatments

An introduction to modern MS treatments BETAFERON is a Prescription Medicine. Use strictly as directed. Consult your pharmacist or other health professional in case of side effects. BETAFERON is reimbursed for some patients. See your neurologist

More information

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

Relapsing-remitting multiple sclerosis Ambulatory with or without aid AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date

More information

MS Treatments Aubagio TM

MS Treatments Aubagio TM 1 MSology Essentials Series Aubagio TM (teriflunomide) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Bonnie Blain Central Alberta MS Clinic, Red Deer, Alberta

More information

Package leaflet: Information for the patient. TYSABRI 300 mg concentrate for solution for infusion natalizumab

Package leaflet: Information for the patient. TYSABRI 300 mg concentrate for solution for infusion natalizumab Package leaflet: Information for the patient TYSABRI 300 mg concentrate for solution for infusion natalizumab This medicine is subject to additional monitoring. This will allow quick identification of

More information

New Treatment Options for MS Patients: Understanding risks versus benefits

New Treatment Options for MS Patients: Understanding risks versus benefits New Treatment Options for MS Patients: Understanding risks versus benefits By Michael A. Meyer, MD Department of Neurology, Sisters Hospital, Buffalo, NY Objectives: 1. to understand fundamentals of MS

More information

Gilenya. Exceptional healthcare, personally delivered

Gilenya. Exceptional healthcare, personally delivered Gilenya Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Gilenya. The decision to start this form of treatment can be difficult.

More information

Original Policy Date

Original Policy Date MP 5.01.20 Tysabri (natalizumab) Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Local Policy/12:2013 Return to Medical Policy Index Disclaimer

More information

AUBMC Multiple Sclerosis Center

AUBMC Multiple Sclerosis Center AUBMC Multiple Sclerosis Center 1 AUBMC Multiple Sclerosis Center The vision of the American University of Beirut Medical Center (AUBMC) is to be the leading academic medical center in Lebanon and the

More information

National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook

National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook Chemotherapy The literal meaning of the term chemotherapy is to treat with a chemical agent, but the term generally refers

More information

What is Multiple Sclerosis? Gener al information

What is Multiple Sclerosis? Gener al information What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal

More information

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Which injectable medication should I take for relapsing-remitting multiple sclerosis? Which injectable medication should I take for relapsing-remitting multiple sclerosis? A decision aid to discuss options with your doctor This decision aid is for you if you: Have multiple sclerosis Have

More information

The flu vaccination for the winter of 2012/13. Who should have it, and why. Includes information for pregnant women

The flu vaccination for the winter of 2012/13. Who should have it, and why. Includes information for pregnant women The flu vaccination for the winter of 2012/13 Who should have it, and why Includes information for pregnant women Introduction This leaflet explains how you can protect yourself against flu this coming

More information

Managing the Symptoms of Multiple Sclerosis. Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner

Managing the Symptoms of Multiple Sclerosis. Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner Managing the Symptoms of Multiple Sclerosis Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner What is Multiple Sclerosis An autoimmune disease that affects the central nervous system (CNS) The immune

More information

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab Package leaflet: Information for the patient Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab This medicine is subject to additional monitoring. This will allow quick identification

More information

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

A blood sample will be collected annually for up to 2 years for JCV antibody testing. Mellen Center Currently Enrolling Non-Treatment Trials STRATIFY-2 JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri Primary Investigator:

More information

Summary HTA. Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C. HTA-Report Summary

Summary HTA. Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C. HTA-Report Summary Summary HTA HTA-Report Summary Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C Health policy background Multiple sclerosis (MS) is a chronic inflammatory disease

More information

TAKING THE NEXT STEP

TAKING THE NEXT STEP FOR ADULTS WITH MS TAKING THE NEXT STEP AMPYRA TREATMENT GUIDE walking better matters See the Patient Medication Guide below. About AMPYRA (dalfampridine) Extended release tablets How is AMPYRA different?

More information

CBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area

CBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area April 2013 Experts at your fingertips call now CBT IN THE CITY Check out our new services in you local area contents. A message from Susie, Information Multiple Sclerosis CBT can make a difference on the

More information

Summary of the risk management plan (RMP) for Cosentyx (secukinumab)

Summary of the risk management plan (RMP) for Cosentyx (secukinumab) EMA/775515/2014 Summary of the risk management plan (RMP) for Cosentyx (secukinumab) This is a summary of the risk management plan (RMP) for Cosentyx, which details the measures to be taken in order to

More information

Disease modifying drug therapy

Disease modifying drug therapy Disease modifying drug therapy what you need to know Third Edition Karen Alldus Simon Webster SECTION 2 We hope you find the information in this book helpful. If you would like to speak with someone about

More information

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your

More information

Subject: Tecfidera (dimethyl fumarate): new measures to minimise the risk of PML enhanced monitoring and stopping rules

Subject: Tecfidera (dimethyl fumarate): new measures to minimise the risk of PML enhanced monitoring and stopping rules Date: 25 th November 2015 Subject: Tecfidera (dimethyl fumarate): new measures to minimise the risk of PML enhanced monitoring and stopping rules Dear Healthcare Professional In agreement with the European

More information

New biologic drugs for arthritis

New biologic drugs for arthritis 1 Biologic drugs (or biologics ) are used to treat many types of inflammatory arthritis such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus and juvenile arthritis. They are

More information

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004. Understanding Multiple Sclerosis Tim, diagnosed in 2004. What Is Multiple Sclerosis? Multiple sclerosis (MS) is a neurologic disorder that affects the central nervous system (CNS). The CNS includes the

More information

The flu vaccination. Winter 2013/14. Who should have it and why. Includes information for pregnant women

The flu vaccination. Winter 2013/14. Who should have it and why. Includes information for pregnant women The flu vaccination Winter 2013/14 Who should have it and why Includes information for pregnant women Introduction This leaflet explains how you can protect yourself against flu this coming winter, and

More information

INFUSE Bone Graft (rhbmp-2/acs)

INFUSE Bone Graft (rhbmp-2/acs) 1 INFUSE Bone Graft (rhbmp-2/acs) For patients who need more bone to place dental implants Enjoy living with INFUSE Bone Graft. www.medtronic.com Medtronic Spinal and Biologics Business Worldwide Headquarters

More information

Progress in MS: Current and Emerging Therapies

Progress in MS: Current and Emerging Therapies Progress in MS: Current and Emerging Therapies Presented by: Dr. Kathryn Giles, MD MSc FRCPC The MS Society gratefully acknowledges the grant received from Biogen Idec Canada, which makes possible the

More information

Vaccination during pregnancy protects both mother and unborn child.

Vaccination during pregnancy protects both mother and unborn child. Grippeimpfung (Englisch) Schwangere Information for expectant mothers Flu Vaccination Vaccination during pregnancy protects both mother and unborn child. Staying healthy during pregnancy During pregnancy,

More information

A Definition of Multiple Sclerosis

A Definition of Multiple Sclerosis English 182 READING PRACTICE by Alyx Meltzer, Spring 2009 Vocabulary Preview (see bolded, underlined words) gait: (n) a particular way of walking transient: (adj) temporary; synonym = transitory remission:

More information

WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS,

WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, FACT SHEET BRANDED/GENERIC NAME: ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) ABRAXANE is an albumin-bound form of paclitaxel with a

More information

CNS DEMYLINATING DISORDERS

CNS DEMYLINATING DISORDERS CNS DEMYLINATING DISORDERS Multiple sclerosis A Dutch saint named Lidwina, who died in 1433, may have been one of the first known MS patients. After she fell while ice skating, she developed symptoms such

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

QUESTIONS TO ASK MY DOCTOR

QUESTIONS TO ASK MY DOCTOR Be a part of the treatment decision by asking questions QUESTIONS TO ASK MY DOCTOR FOR PATIENTS WITH ADVANCED STOMACH OR GASTROESOPHAGEAL JUNCTION (GEJ) CANCER CYRAMZA (ramucirumab) is used alone or in

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start

More information

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital i InfoNEURO Montreal Neurological Hospital INFORMATION FOR PATIENTS Mitoxantrone For multiple sclerosis Centre universitaire de santé McGill McGill University Health Centre Collaborators: D. Lowden Clinical

More information

Multiple sclerosis. Great Ormond Street Hospital for Children NHS Foundation Trust: Information for young people. What is Multiple Sclerosis?

Multiple sclerosis. Great Ormond Street Hospital for Children NHS Foundation Trust: Information for young people. What is Multiple Sclerosis? Great Ormond Street Hospital for Children NHS Foundation Trust: Information for young people Multiple sclerosis When young people are told that they have a diagnosis of Multiple Sclerosis (MS) they usually

More information

Multiple Sclerosis: What You Need To Know. For Professionals

Multiple Sclerosis: What You Need To Know. For Professionals Multiple Sclerosis: What You Need To Know For Professionals What will I learn today? The Basics: What is MS? Living with MS: A Family Affair We Can Help: The National MS Society What MS Is: MS is thought

More information

THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL

THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL See page 12 for FREE* TRIAL OFFER *Limitations and restrictions apply. Actor portrayal AMPYRA (dalfampridine)

More information

X-Plain H1N1 Flu (Swine Flu) Reference Summary

X-Plain H1N1 Flu (Swine Flu) Reference Summary X-Plain H1N1 Flu (Swine Flu) Reference Summary Introduction H1N1 flu, also called swine flu, is a respiratory disease of pigs that has now spread to humans. Swine refers to animals such as pigs, hogs,

More information

Version History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author

Version History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author Version History Policy Title Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields

More information

Package leaflet: Information for the patient. TYSABRI 300 mg concentrate for solution for infusion natalizumab

Package leaflet: Information for the patient. TYSABRI 300 mg concentrate for solution for infusion natalizumab Package leaflet: Information for the patient TYSABRI 300 mg concentrate for solution for infusion natalizumab This medicine is subject to additional monitoring. This will allow quick identification of

More information

Sarcoidosis. Exceptional healthcare, personally delivered

Sarcoidosis. Exceptional healthcare, personally delivered Sarcoidosis Exceptional healthcare, personally delivered The Bristol Interstitial Lung Disease Service at North Bristol NHS Trust cares for a catchment area of around 550,000 people (plus additional referrals

More information

Disease modifying drug therapy

Disease modifying drug therapy Disease modifying drug therapy New edition for 2014-15 We hope you find the information in this book helpful. If you would like to speak with someone about any aspect of MS, contact the MS Trust information

More information

TYSABRI Risk Management Plan. Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc

TYSABRI Risk Management Plan. Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc 76 TYSABRI Risk Management Plan Carmen Bozic, MD Vice President Drug Safety and Risk Management Biogen Idec Inc 77 Presentation Outline Overview and Goals of Plan Risk Minimization Plan Risk Assessment

More information

AVONEX. What is Avonex?

AVONEX. What is Avonex? AVONEX What is Avonex? Avonex is the brand name for a disease modifying treatment for people with MS. The active ingredient is interferon beta 1a, which comes in a solution or powder, and is given by injection.

More information

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab) Patient Guide Important information for patients starting therapy with LEMTRADA (alemtuzumab) This medicinal product is subject to additional monitoring. This will allow quick identification of new safety

More information

Optic Neuritis. A Patient s Guide

Optic Neuritis. A Patient s Guide Optic Neuritis Sashank Prasad, MD www.brighamandwomens.org/neuro-ophthalmology A Patient s Guide Symptoms Prognosis Treatment Sashank Prasad, MD What are the symptoms of Optic Neuritis? Symptoms An episode

More information

swine flu vaccination:

swine flu vaccination: swine flu vaccination: what you need to know Flu. Protect yourself and others. Contents What is swine flu?............... 3 About the swine flu vaccine....... 4 What else do I need to know?...... 8 What

More information

What You Need to Know About Lung Cancer Immunotherapy

What You Need to Know About Lung Cancer Immunotherapy What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer

More information

Getting A New Pancreas Facts About Pancreas Transplants

Getting A New Pancreas Facts About Pancreas Transplants Release Date October 1, 2003 Revised December 2006 Revised March 2012 Getting A New Pancreas Facts About Pancreas Transplants American Society of Transplantation 1120 Route 73, Suite 200 Mount Laurel,

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TALTZ ixekizumab

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TALTZ ixekizumab READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr TALTZ ixekizumab www.lilly.ca Lilly Read this carefully before you start taking TALTZ and each time you get a refill.

More information

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain.

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain. Optic Neuritis Your doctor thinks that you have had an episode of optic neuritis. This is the most common cause of sudden visual loss in a young patient. It is often associated with discomfort in or around

More information

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate Read this Medication Guide before you start receiving mitoxantrone and each time you receive mitoxantrone. There may be new information.

More information

CAMBRIDGE UNIVERSITY CENTRE FOR BRAIN REPAIR A layman's account of our scientific objectives What is Brain Damage? Many forms of trauma and disease affect the nervous system to produce permanent neurological

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate.

Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate. EMA/614203/2010 EMEA/H/C/000165 EPAR summary for the public rituximab This is a summary of the European public assessment report (EPAR) for. It explains how the Committee for Medicinal Products for Human

More information

Mycophenolate. Dosage and monitoring record for patients with interstitial lung disease

Mycophenolate. Dosage and monitoring record for patients with interstitial lung disease Mycophenolate Dosage and monitoring record for patients with interstitial lung disease This booklet contains information about your immunosuppressant treatment. Keep this booklet with you at all times

More information

AMPYRA (dalfampridine) Important Safety Information

AMPYRA (dalfampridine) Important Safety Information NEWS RELEASE Acorda to Present New rhigm22 and AMPYRA (dalfampridine) Data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 10/7/2015 ARDSLEY, N.Y.--(BUSINESS

More information

Use of oral steroids in Multiple Sclerosis

Use of oral steroids in Multiple Sclerosis Use of oral steroids in Multiple Sclerosis Information for patients and carers Neurology Department Aberdeen Royal Infirmary What are steroids? The steroids used to treat Multiple Sclerosis (MS) relapses

More information

Disease modifying drug therapy. what you need to know

Disease modifying drug therapy. what you need to know Disease modifying drug therapy what you need to know Contact information Neurologist s name: Neurologist s secretary: Telephone number: MS specialist nurse: Telephone number: Manufacturer helpline number:

More information

Infl ectra for rheumatoid arthritis

Infl ectra for rheumatoid arthritis Infl ectra for rheumatoid arthritis Some important information to get you started with your treatment This booklet is intended only for use by patients who have been prescribed Inflectra. Introduction

More information

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions

More information

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author MULTIPLE SCLEROSIS Mary Beth Rensberger, RN, BSN, MPH Author All rights reserved. Purchasers of this module are permitted to reproduce the forms contained herein for their individual internal use only.

More information

Treatments for MS: Immunotherapy. Gilenya (fingolimod) Glatiramer acetate (Copaxone )

Treatments for MS: Immunotherapy. Gilenya (fingolimod) Glatiramer acetate (Copaxone ) Treatments for MS: Immunotherapy There are currently several disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity

More information

Brain cancer. What is brain cancer? The central nervous system

Brain cancer. What is brain cancer? The central nervous system Brain cancer What is brain cancer? Brain cancer occurs when cells in the brain or the spinal cord start to grow out of control, forming a tumour or mass. The spinal cord is the thick bundle of nerves that

More information

Medication Policy Manual. Topic: Gilenya, fingolimod Date of Origin: November 22, 2010

Medication Policy Manual. Topic: Gilenya, fingolimod Date of Origin: November 22, 2010 Medication Policy Manual Policy No: dru229 Topic: Gilenya, fingolimod Date of Origin: November 22, 2010 Committee Approval Date: December 11, 2015 Next Review Date: December 2016 Effective Date: January

More information

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets. Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.

More information

A neurologist would assess your eligibility and suitability for the DMTs.

A neurologist would assess your eligibility and suitability for the DMTs. Choices Disease Modifying Treatments Disease modifying treatments (DMTs) are medications which modify the disease course. They target inflammation and are designed to reduce the damage caused by relapses.

More information

calendar Your treatment for VELCADE (bortezomib) For the treatment of patients with multiple myeloma

calendar Your treatment for VELCADE (bortezomib) For the treatment of patients with multiple myeloma For the treatment of patients with multiple myeloma Your treatment calendar for VELCADE (bortezomib) VELCADE (bortezomib) is approved for the treatment of patients with multiple myeloma (a cancer of the

More information

Choices. Diagnosis. Read me

Choices. Diagnosis. Read me Choices Diagnosis Read me Diagnosis Diagnosing multiple sclerosis can be complicated, not least because there is no single test that conclusively indicates the presence of the condition. Multiple sclerosis

More information

I B2.4. Design of the patient information leaflet for VariQuin

I B2.4. Design of the patient information leaflet for VariQuin (English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to

More information

Summary of the risk management plan (RMP) for Accofil (filgrastim)

Summary of the risk management plan (RMP) for Accofil (filgrastim) EMA/475472/2014 Summary of the risk management plan (RMP) for Accofil (filgrastim) This is a summary of the risk management plan (RMP) for Accofil, which details the measures to be taken in order to ensure

More information

Intravenous Immunoglobulin in Neurological disorders

Intravenous Immunoglobulin in Neurological disorders Intravenous Immunoglobulin in Neurological disorders Exceptional healthcare, personally delivered What is Intravenous Immunoglobulin (IVIg)? Intravenous immunoglobulin (IVIg) is a blood product that combines

More information

Natalizumab (Tysabri) and PMLthe current figures. Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY

Natalizumab (Tysabri) and PMLthe current figures. Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY Natalizumab (Tysabri) and PMLthe current figures Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY Humanised MAB Natalizumab Specific binding to a4-integrin

More information

Economic Evaluation of Natalizumab (Tysabri) for the treatment of relapsing remitting multiple sclerosis that is rapidly evolving and severe or

Economic Evaluation of Natalizumab (Tysabri) for the treatment of relapsing remitting multiple sclerosis that is rapidly evolving and severe or Economic Evaluation of Natalizumab (Tysabri) for the treatment of relapsing remitting multiple sclerosis that is rapidly evolving and severe or sub-optimally treated Summary In January 2007 Biogen Idec

More information

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

Steroids for Myasthenia Gravis

Steroids for Myasthenia Gravis Neurology and Pharmacy directorate Steroids for Myasthenia Gravis Introduction This leaflet provides information on a medicine called steroids when it is used to treat myasthenia gravis. After reading

More information

Biologic Treatments for Rheumatoid Arthritis

Biologic Treatments for Rheumatoid Arthritis Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been

More information

Welcome to Mycophenolate REMS What You Need to Know Your Role Your Birth Control Options Reporting Your Pregnancy...

Welcome to Mycophenolate REMS What You Need to Know Your Role Your Birth Control Options Reporting Your Pregnancy... Table of Contents Welcome to Mycophenolate REMS... 5 What You Need to Know... 6 Your Role... 7 Your Birth Control Options... 8 Reporting Your Pregnancy... 10 Important Resources... 11 Other Resources...

More information

Information About Medicines for Multiple Sclerosis

Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain

More information

The MS Disease- Modifying Medications GENERAL INFORMATION

The MS Disease- Modifying Medications GENERAL INFORMATION The MS Disease- Modifying Medications GENERAL INFORMATION Current as of March 2014. This online brochure is updated with breaking news as required. If you have a printed a copy of this publication, please

More information

Blood Transfusion. Red Blood Cells White Blood Cells Platelets

Blood Transfusion. Red Blood Cells White Blood Cells Platelets Blood Transfusion Introduction Blood transfusions are very common. Each year, almost 5 million Americans need a blood transfusion. Blood transfusions are given to replace blood lost during surgery or serious

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION GRASTEK (Standardized Allergen Extract, Timothy Grass (Phleum pratense) Sublingual Tablets 2800 BAU) This leaflet is part III of a three-part "Product Monograph" published

More information

MEDICATION GUIDE STELARA

MEDICATION GUIDE STELARA MEDICATION GUIDE STELARA (stel ar a) (ustekinumab) Injection What is the most important information I should know about STELARA? STELARA is a medicine that affects your immune system. STELARA can increase

More information